Cargando…
CCR5 Blockade in Inflammatory PML and PML-IRIS Associated With Chronic Inflammatory Diseases' Treatments
BACKGROUND AND OBJECTIVES: Progressive multifocal leukoencephalopathy (PML) is a disabling neurologic disorder resulting from the infection of the CNS by JC polyomavirus in immunocompromised individuals. For the last 2 decades, increasing use of immunotherapies leads to iatrogenic PML. Iatrogenic PM...
Autores principales: | Bernard-Valnet, Raphael, Moisset, Xavier, Maubeuge, Nicolas, Lefebvre, Mathilde, Ouallet, Jean-Christophe, Roumier, Mathilde, Lebrun-Frenay, Christine, Ciron, Jonathan, Biotti, Damien, Clavelou, Pierre, Godeau, Bertrand, Du Pasquier, Renaud A., Martin-Blondel, Guillaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8564863/ https://www.ncbi.nlm.nih.gov/pubmed/34728496 http://dx.doi.org/10.1212/NXI.0000000000001097 |
Ejemplares similares
-
An unusual case of miliary PML-IRIS in an HIV+ patient
por: Cuendet, David, et al.
Publicado: (2017) -
Neurological complications in HIV patients – a case of PML-IRIS
por: Gliga, Smaranda, et al.
Publicado: (2014) -
Severe early natalizumab-associated PML in MS: Effective control of PML-IRIS with maraviroc
por: Bsteh, Gabriel, et al.
Publicado: (2017) -
Pembrolizumab as a treatment for PML?: Waiting for Godot
por: Du Pasquier, Renaud A.
Publicado: (2019) -
Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment
por: Himedan, Mai, et al.
Publicado: (2017)